HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of amoxicillin and metronidazole combination for the management of generalized aggressive periodontitis.

AbstractBACKGROUND:
The aim of this study is to evaluate the effects of metronidazole-amoxicillin combination on clinical and microbiologic parameters in patients with generalized aggressive periodontitis.
METHODS:
Twenty-eight patients were randomly included. The test group (n = 12) received amoxicillin-metronidazole combination and scaling and root planing; the control group (n = 16) received scaling and root planing alone. In addition to the clinical examinations, subgingival plaque samples were analyzed for total cultivable bacteria and the presence of Porphyromonas gingivalis, Tannerella forsythia (previously T. forsythensis), Treponema denticola, Prevotella intermedia, Prevotella nigrescens, Prevotella pallens, and Aggregatibacter actinomycetemcomitans (previously Actinobacillus actinomycetemcomitans) using polymerase chain reaction.
RESULTS:
All clinical parameters improved significantly compared to baseline (P <0.05) in both groups. There was a statistically significant reduction of pockets and clinical attachment gain in the combined group compared to the control group (P <0.05). Total counts of bacteria also decreased significantly at 3 and 6 months in both groups (P <0.05). T. denticola and T. forsythia were the most prevalent bacteria throughout the study. T. denticola showed a continuous decrease over 6 months in the test group, whereas no change was seen in the control group beyond 3 months. P. gingivalis decreased significantly at 3 months (P <0.05), whereas T. forsythia was the only pathogen decreased below detection limits by the combination therapy with a significant difference compared to the control group (P <0.05).
CONCLUSIONS:
The results from this study suggest that combined amoxicillin and metronidazole use as an adjunct to scaling and root planing leads to better clinical healing compared to mechanical treatment alone. The polypharmaceutical approach used results in a significant and substantial decrease in T. forsythia and prevents its recolonization for 6 months, suggesting that T. forsythia may determine the long-term stability of periodontal treatment outcomes.
AuthorsEmine Cifcibasi Yek, Serdar Cintan, Nursen Topcuoglu, Guven Kulekci, Halim Issever, Alpdogan Kantarci
JournalJournal of periodontology (J Periodontol) Vol. 81 Issue 7 Pg. 964-74 (Jul 2010) ISSN: 1943-3670 [Electronic] United States
PMID20214441 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Drug Combinations
  • Metronidazole
  • Amoxicillin
Topics
  • Adolescent
  • Adult
  • Aggregatibacter actinomycetemcomitans (drug effects)
  • Aggressive Periodontitis (drug therapy, microbiology)
  • Amoxicillin (administration & dosage, therapeutic use)
  • Anti-Bacterial Agents (administration & dosage, therapeutic use)
  • Anti-Infective Agents (administration & dosage, therapeutic use)
  • Bacteroides (drug effects)
  • Colony Count, Microbial
  • Combined Modality Therapy
  • Dental Plaque (microbiology)
  • Dental Scaling
  • Drug Combinations
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Metronidazole (administration & dosage, therapeutic use)
  • Middle Aged
  • Periodontal Attachment Loss (drug therapy, microbiology)
  • Periodontal Pocket (drug therapy, microbiology)
  • Porphyromonas gingivalis (drug effects)
  • Prevotella (drug effects)
  • Prevotella intermedia (drug effects)
  • Prevotella nigrescens (drug effects)
  • Root Planing
  • Treatment Outcome
  • Treponema denticola (drug effects)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: